Literature DB >> 7220153

Theophylline metabolism during the first month of life and development.

M Bonati, R Latini, G Marra, B M Assael, R Parini.   

Abstract

The metabolic pathway of theophylline (T) was studied in 12 newborns, one young infant, six children, and three adult volunteers. T was injected IV, and blood and urine samples were assayed for T, caffeine (C), and their metabolites by a high-pressure liquid chromatography technique. We confirmed the methylation of T to C in newborn infants but not in older subjects. Demethylation of T to 3-methylxanthine was found in the young infant, in children, and in adults, but not in newborns. The major products excreted by neonates were T, 1-methyluric acid, and 1,3-dimethyluric acid. Children excreted a larger fraction of methyluric acids than adults. Renal and body clearance of T and C are reported and discussed in relation to the age.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7220153     DOI: 10.1203/00006450-198104000-00003

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  10 in total

Review 1.  Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part II).

Authors:  J B Besunder; M D Reed; J L Blumer
Journal:  Clin Pharmacokinet       Date:  1988-05       Impact factor: 6.447

2.  Application of a Physiologically Based Pharmacokinetic Approach to Predict Theophylline Pharmacokinetics Using Virtual Non-Pregnant, Pregnant, Fetal, Breast-Feeding, and Neonatal Populations.

Authors:  Khaled Abduljalil; Iain Gardner; Masoud Jamei
Journal:  Front Pediatr       Date:  2022-05-12       Impact factor: 3.569

3.  Comparison of the effects of theophylline and caffeine on serum erythropoietin concentration in premature infants.

Authors:  S Fang; R A Sherwood; H R Gamsu; J T Marsden; T J Peters; A Greenough
Journal:  Eur J Pediatr       Date:  1998-05       Impact factor: 3.183

Review 4.  Theophylline poisoning. Pharmacological considerations and clinical management.

Authors:  P Gaudreault; J Guay
Journal:  Med Toxicol       Date:  1986 May-Jun

Review 5.  Ontogeny of hepatic and renal systemic clearance pathways in infants: part I.

Authors:  Jane Alcorn; Patrick J McNamara
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

6.  Pharmacokinetics of theophylline and its metabolites in rabbits.

Authors:  A Celardo; G L Traina; A Jankowski; M Bonati
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1985 Oct-Dec       Impact factor: 2.441

7.  Pharmacokinetics of theophylline in infants with bronchiolitis.

Authors:  T G Franko; D A Powell; M C Nahata
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

8.  Total theophylline clearance in childhood: the influence of age-dependent changes in metabolism and elimination.

Authors:  D Berdel; R Süverkrüp; G Heimann; A von Berg; N Liappis; A Stühmer
Journal:  Eur J Pediatr       Date:  1987-01       Impact factor: 3.183

9.  Polymorphism of theophylline metabolism in man.

Authors:  C A Miller; L B Slusher; E S Vesell
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

Review 10.  Pharmacokinetics in the infant.

Authors:  R L Milsap; W J Jusko
Journal:  Environ Health Perspect       Date:  1994-12       Impact factor: 9.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.